New research shows that that the diabetes/obesity medication tirzepatide can cause clinically meaningful improvements in blood sugar control and weight...
Stockholm, Sweden – June 9, 2025. SIGRID, the Swedish healthtech innovator behind the patented...
ADM, a global leader in innovative solutions from nature, has announced new findings from a recent clinical study...
Introduction Behavioral and lifestyle changes are considered a viable first-line treatment for diet-related noncommunicable diseases, including Type 2 Diabetes (T2D),...
ORIGINAL RESEARCH article Front. Nutr. Sec. Clinical Nutrition Volume 12 - 2025 | doi: 10.3389/fnut.2025.1548609 This article is part of...
